A questionnaire to measure the impact of cluster headaches
In a blog for Cluster Headache Awareness day, Ruth Ruscheweyh and Katharina Kamm introduce the Cluster Headache Impact Questionnaire (CHIQ) which aims to… Read more »
Dr. Ruth Ruscheweyh is a resident at the Department of Neurology of the Ludwig Maximilians University hospital in Munich, Germany. She is the head of the Headache Registry of the German Migraine and Headache Society. Her research interests are patient-reported outcomes and psychological factors in headache and pain on the one hand, and calcitonin gene-related peptide (CGRP) and descending pain inhibition on the other.
Dr. Katharina Kamm is a resident at the Department of Neurology of the LMU University Hospital and at the Upper Bavarian Headache Center of the LMU University Hospital Munich, Germany. Her research focuses on primary headache disorders. In this respect, she is especially interested in cluster headache as well as the role of calcitonin gene-related peptide in migraine and cluster headache.
Dr. Katharina Kamm is a resident at the Department of Neurology of the LMU University Hospital and at the Upper Bavarian Headache Center of the LMU University Hospital Munich, Germany. Her research focuses on primary headache disorders. In this respect, she is especially interested in cluster headache as well as the role of calcitonin gene-related peptide in migraine and cluster headache.
Latest posts by Ruth Ruscheweyh & Katharina Kamm (see all)
- A questionnaire to measure the impact of cluster headaches - 17th March 2022